Rivaroxaban 10mg Tablets

Rivaroxaban 10mg is an oral anticoagulant used to prevent deep-vein thrombosis and pulmonary embolism after hip or knee replacement, and to reduce recurrence after an initial clot-treatment course.
The 10mg prevention dose is commonly taken once daily, with or without food. After surgery, the first dose is timed after bleeding has been controlled. The duration depends on the specific prevention setting and is not the same for every operation or patient.
Rivaroxaban directly inhibits activated factor X, or factor Xa. This reduces thrombin generation and the formation of fibrin clots without acting as a platelet inhibitor like aspirin.
Bruising, nosebleeds, gum bleeding and anaemia can occur. Bleeding that will not stop, black stools, blood in urine, vomiting blood, a severe headache after a fall or sudden weakness needs urgent assessment.
Do not use during active significant bleeding or liver disease that impairs clotting. Kidney function affects the choice of dose and regimen. Strong CYP3A4/P-glycoprotein inhibitors or inducers can alter rivaroxaban levels. Tell the surgical or dental team before a procedure, particularly a spinal or epidural procedure. NSAIDs, antiplatelets and other anticoagulants increase bleeding risk. The 10mg prevention tablet does not replace the initial higher-dose regimen for a newly diagnosed DVT or pulmonary embolism.
Helps reduce the risk of a new or recurrent clot during periods of increased venous-clot risk.
Routine INR testing is not used to adjust rivaroxaban. Kidney function, haemoglobin, bleeding symptoms and interactions still need periodic assessment.
No. It reduces further clot formation while the body's own processes gradually break down the existing clot.
Ibuprofen, naproxen and other NSAIDs can increase bleeding when combined with rivaroxaban. Do not add them for pain without first arranging a suitable pain-relief option.
The dentist needs to plan for bleeding and the timing of treatment. Do not miss rivaroxaban doses on your own before dental work.
Factor Xa: an activated clotting protein involved in thrombin generation. Anticoagulant: a medicine reducing blood-clot formation. Venous thromboembolism: a clot in a deep vein or lung circulation. Non-valvular atrial fibrillation: an irregular atrial rhythm without certain valve conditions. Haemostasis: the process of stopping bleeding.; AR: Rivaroxaban 10mg أقراص; FR: Rivaroxaban 10mg comprimés; PT: Rivaroxaban 10mg comprimidos; ES: Rivaroxaban 10mg comprimidos; RU: Rivaroxaban 10mg таблетки; ID: Rivaroxaban 10mg tablet; VI: Rivaroxaban 10mg viên nén; MS: Rivaroxaban 10mg tablet; TL: Rivaroxaban 10mg tableta; ZH-SG: Rivaroxaban 10mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Rivaroxaban 10mg Tablets under Blood Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Rivaroxaban 10mg Tablets